bibliographic entry 10751008 [be/10751008]
https://w3id.org/oc/corpus/be/10751008

is a

• bibliographic reference

content

• Kreisl, TN, Kim, L, Moore, K, Duic, P, Royce, C, Stroud, I, Garren, N, Mackey, M, Butman, JA, Camphausen, K, Park, J, Albert, PS, Fine, HA. Phase ii trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma, J Clin Oncol, 2009, 27, 740, 745, PMID: 19114704

references

• https://w3id.org/oc/corpus/br/1948108